Skip to content

AAV

Optimised transient- and scalable production systems for high quality, high titre AAV production.

Transient AAV production

Our reconfigured Rep-Cap plasmid, modified Ad5 helper and GMP banked clonal suspension HEK293 cell line offer improved AAV quality and yield.

TESSA™: scalable AAV production

Our proprietary Tet-enabled self silencing adenoviral (TESSA™) AAV manufacturing system delivers high-yield, high quality AAV in a scalable, contaminant, chemical and transfection free process.

From our experts to yours, our scientists offer ongoing comprehensive technical support so you can have complete confidence in the performance of our technologies once transferred to your own facilities.

AAV at the edge of impossible

OXGENE's transient AAV production system and process development support facilitates high quality, high-titre AAV production. Our revolutionary new TESSA™ scalable system    offers a plasmid free alternative for large scale clinical manufacture.

Latest News

View all Gene Therapy news

Latest Technical Resources

View all Gene Therapy resources

Adenovirus Engineering

Optimised adenovirus engineering for gene therapy and oncology applications

Lentivirus Engineering

XLenti™: transient production platform and packaging and producer cell lines

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.

Login

Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.